From: HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
Characteristics | No |
---|---|
Age, years | |
≥ 50 | 42 |
< 50 | 22 |
Histological type | |
Serous Adenocarcinoma | 50 |
Mucinous Adenocarcinoma | 2 |
Endometrioid Adenocarcinoma | 6 |
Clear Cell Carcinoma | 5 |
Transitional Cell Carcinoma | 1 |
FIGO stage | |
I | 9 |
II | 6 |
III | 36 |
IV | 13 |
Differentiation | |
Poor | 27 |
Moderate | 24 |
Well | 13 |
Ascites | |
+ | 11 |
− | 53 |
Vessel Invasion | |
+ | 3 |
− | 61 |
Lymph Node | |
+ | 8 |
− | 56 |
Platinum Sensitivity | |
Sensitive | 50 |
Resistance | 14 |
Relapse | |
+ | 27 |
− | 37 |